Lifeboat Foundation

Scott Sellers is the co-founder and CEO of Azul, with 30 years of experience as an entrepreneur and executive in the technology industry.

For the first time in a decade, controlling cloud costs has surpassed security as the top cloud management challenge facing IT professionals, according to a survey by Flexera. An Andreessen Horowitz study also said that up to $1 trillion in market capitalization is weighed down by overspending in the cloud. Today, challenging economic conditions, rising costs, increasingly stringent performance SLAs and the need for more resources are squeezing organizations that want to remain in the cloud without overspending.

Many organizations still struggle to connect the dots between the value they deliver via the cloud and the costs required to deliver that value. Without a clear understanding of that basic relationship, it is difficult for teams to hold productive conversations about costs. Engineering departments don’t know what to prioritize; cloud architects lack a direction on designing, developing and managing solutions; product managers face difficulties pricing their solutions; and executives wonder where all the money is going.

The protective effects of vaccines have particularly been highlighted during the recent COVID-19 pandemic. Countries able to offer the vaccine demonstrate lowered infection rates and have kick-started the recovery of their economies.

The COVID-19 pandemic has also highlighted the need to proactively develop medical countermeasures to novel pathogens, in addition to advancing supply and manufacturing capacities to meet global demands.

Investing in vaccine manufacturing has both economic and societal benefits, in addition to protecting human health and limiting infection spread.

The quarterly reports by these tech behemoths show their efforts to increase AI productivity in the face of growing economic worries.

The US tech giants like Alphabet, Microsoft, Amazon, and Meta are increasing their large language model (LLM) investments as a show of their dedication to utilizing the power of artificial intelligence (AI) while cutting costs and jobs.

Since the launch of OpenAI’s ChatGPT chatbot in late 2022, these businesses have put their artificial intelligence AI models on steroids to compete in the market, CNBC reported on Friday.

Continue reading “Google, Microsoft, Amazon, & Meta put AI on steroids while cutting jobs” »

In Silicon Valley, some of the brightest minds believe a universal basic income (UBI) that guarantees people unrestricted cash payments will help them to survive and thrive as advanced technologies eliminate more careers as we know them, from white collar and creative jobs — lawyers, journalists, artists, software engineers — to labor roles. The idea has gained enough traction that dozens of guaranteed income programs have been started in U.S. cities since 2020.

Yet even Sam Altman, the CEO of OpenAI and one of the highest-profile proponents of UBI, doesn’t believe that it’s a complete solution. As he said during a sit-down earlier this year, “I think it is a little part of the solution. I think it’s great. I think as [advanced artificial intelligence] participates more and more in the economy, we should distribute wealth and resources much more than we have and that will be important over time. But I don’t think that’s going to solve the problem. I don’t think that’s going to give people meaning, I don’t think it means people are going to entirely stop trying to create and do new things and whatever else. So I would consider it an enabling technology, but not a plan for society.”

Continue reading “We all contribute — should we get paid for that?” »

Despite the impressive recent progress in AI capabilities, there are reasons why AI may be incapable of possessing a full “general intelligence”. And although AI will continue to transform the workplace, some important jobs will remain outside the reach of AI. In other words, the Economic Singularity may not happen, and AGI may be impossible.

These are views defended by our guest in this episode, Kenneth Cukier, the Deputy Executive Editor of The Economist newspaper.

Continue reading “A defence of human uniqueness against AI encroachment, with Kenn Cukier” »

It is an unsettling moment. Critics argue the rush to AI comes too fast — while competitive pressure— among giants like Google and start-ups you’ve never heard of, is propelling humanity into the future ready or not.

Sundar Pichai: But I think if take a 10-year outlook, it is so clear to me, we will have some form of very capable intelligence that can do amazing things. And we need to adapt as a society for it.

Google CEO Sundar Pichai told us society must quickly adapt with regulations for AI in the economy, laws to punish abuse, and treaties among nations to make AI safe for the world.

To build a workforce that can meet the expected future demand in the quantum sector, we need to train many more quantum-literate educators and marshal support for them.

In 2018 the US federal government passed the National Quantum Initiative Act, a program designed to accelerate the country’s quantum research and development activities. In the next decade, quantum information science and quantum technologies are expected to have a significant impact on the US economy, as well as on that of other countries. To fulfill that promise, the US will need a “quantum-capable” workforce that is conversant with the core aspects of quantum technologies and is large enough to meet the expected demand. But even now, as quantum-career opportunities are just starting to appear, supply falls behind demand; according to a 2022 report, there is currently only around one qualified candidate for every three quantum job openings [1]. We call for education institutions and funding agencies to invest significantly in workforce development efforts to prevent the worsening of this dearth.

Most of today’s jobs in quantum information science and technology (QIST) require detailed knowledge and skills that students typically gain in graduate-level programs [2]. As the quantum industry matures from having a research and development focus toward having a deployment focus, this requirement will likely relax. The change is expected to increase the proportion of QIST jobs compatible with undergraduate-level training. However, 86% of QIST-focused courses currently take place at PhD-granting research institutions [3]. Very few other undergraduate institutions offer opportunities to learn about the subject. To meet the future need, we believe that aspect needs to change with QIST education being incorporated into the curricula at predominantly undergraduate institutions and community colleges in the US. However, adding QIST classes to the curricula at these institutions will be no easy task.

To meet climate commitments, we need to use more batteries across many economic sectors. Battery analytics can help to remove risk and increase uptake.

In the last decade, we have witnessed biology bring us some incredible products and technologies: from mushroom-based packaging to animal-free hotdogs and mRNA vaccines that helped curb a global pandemic. The power of synthetic biology to transform our world cannot be overstated: this industry is projected to contribute to as much as a third of the global economic output by 2030, or nearly $30 trillion, and could impact almost every area of our lives, from the food we eat to the medicine we put in our bodies.

The leaders of this unstoppable bio revolution – many of whom you can meet at the SynBioBeta conference in Oakland, CA, on May 23–25 – are bringing the future closer every day through their ambitious vision, long-range strategy, and proactive oversight. These ten powerful women are shaping our world as company leaders, biosecurity experts, policymakers, and philanthropists focused on charting a new course to a more sustainable, equitable, clean, and safe future.

As an early pioneer in the high-throughput synthesis and sequencing of DNA, Emily Leproust has dedicated her life to democratizing gene synthesis to catapult the growth of synthetic biology applications from medicine, food, agriculture, and industrial chemicals to DNA data storage. She was one of the co-founders of Twist Bioscience in 2013 and is still leading the expanding company as CEO. To say that Twist’s silicon platform was a game-changer for the industry is an understatement. And it is no surprise that Leproust was recently honored with the BIO Rosalind Franklin Award for her work in the biobased economy and biotech innovation.